Genes selected for RT-PCR validation
| Probe set IDs . | T1-CT* . | T2-CT* . | T3-CT* . | B1-CT* . | B2-CT* . | B3-CT* . | Gene title . | Gene symbol . |
|---|---|---|---|---|---|---|---|---|
| B leukemia probe sets | ||||||||
| 1450063_at | −0.33 | −0.20 | −0.19 | 2.59 | 3.05 | 3.01 | Formin 2 | Fmn2 |
| 1429688_at | −0.48 | −0.13 | −0.38 | 3.24 | 2.78 | 2.75 | Aryl hydrocarbon receptor nuclear translocator-like 2 | Arntl2 |
| 1434463_at | −0.45 | −0.48 | −0.29 | 2.98 | 3.36 | 3.39 | Beaded filament structural protein 2, phakinin | Bfsp2 |
| 1423007_a_at | −0.41 | −0.04 | −0.01 | 3.12 | 3.22 | 2.68 | Glial cell line derived neurotrophic factor family receptor | Gfra2 |
| 1426442_at | −0.06 | −0.04 | 0.09 | 3.15 | 2.79 | 2.42 | Glycoprotein m6a | Gpm6a |
| 1425942_a_at | −0.43 | −0.54 | −0.09 | 6.93 | 6.35 | 2.55 | Glycoprotein m6b | Gpm6b |
| T leukemia probe sets | ||||||||
| 1419122_at | 2.33 | 2.16 | 2.85 | −0.41 | −0.07 | −0.15 | Methyltransferase-like 1 | Mettl1 |
| 1451555_at | 2.32 | 3.23 | 2.07 | −0.06 | 0.07 | 0.09 | Neurolysin (metallopeptidase M3 family) | Nln |
| 1432410_a_at | 3.09 | 1.56 | 3.28 | −0.36 | −0.15 | −0.19 | Bone morphogenetic protein 7 | Bmp7 |
| 1451119_a_at | 2.75 | 2.25 | 1.58 | −0.12 | −0.28 | −0.27 | Fibulin 1 | Fbln1 |
| B and T leukemia common probe sets | ||||||||
| 1428142_at | 2.68 | 2.24 | 3.42 | 4.04 | 3.53 | 3.66 | ets variant gene 5 | Etv5 |
| 1418925_at | 2.38 | 1.50 | 1.20 | 2.99 | 2.99 | 2.41 | Cadherin EGF LAG seven-pass G-type receptor 1 | Celsr1 |
| Probe set IDs . | T1-CT* . | T2-CT* . | T3-CT* . | B1-CT* . | B2-CT* . | B3-CT* . | Gene title . | Gene symbol . |
|---|---|---|---|---|---|---|---|---|
| B leukemia probe sets | ||||||||
| 1450063_at | −0.33 | −0.20 | −0.19 | 2.59 | 3.05 | 3.01 | Formin 2 | Fmn2 |
| 1429688_at | −0.48 | −0.13 | −0.38 | 3.24 | 2.78 | 2.75 | Aryl hydrocarbon receptor nuclear translocator-like 2 | Arntl2 |
| 1434463_at | −0.45 | −0.48 | −0.29 | 2.98 | 3.36 | 3.39 | Beaded filament structural protein 2, phakinin | Bfsp2 |
| 1423007_a_at | −0.41 | −0.04 | −0.01 | 3.12 | 3.22 | 2.68 | Glial cell line derived neurotrophic factor family receptor | Gfra2 |
| 1426442_at | −0.06 | −0.04 | 0.09 | 3.15 | 2.79 | 2.42 | Glycoprotein m6a | Gpm6a |
| 1425942_a_at | −0.43 | −0.54 | −0.09 | 6.93 | 6.35 | 2.55 | Glycoprotein m6b | Gpm6b |
| T leukemia probe sets | ||||||||
| 1419122_at | 2.33 | 2.16 | 2.85 | −0.41 | −0.07 | −0.15 | Methyltransferase-like 1 | Mettl1 |
| 1451555_at | 2.32 | 3.23 | 2.07 | −0.06 | 0.07 | 0.09 | Neurolysin (metallopeptidase M3 family) | Nln |
| 1432410_a_at | 3.09 | 1.56 | 3.28 | −0.36 | −0.15 | −0.19 | Bone morphogenetic protein 7 | Bmp7 |
| 1451119_a_at | 2.75 | 2.25 | 1.58 | −0.12 | −0.28 | −0.27 | Fibulin 1 | Fbln1 |
| B and T leukemia common probe sets | ||||||||
| 1428142_at | 2.68 | 2.24 | 3.42 | 4.04 | 3.53 | 3.66 | ets variant gene 5 | Etv5 |
| 1418925_at | 2.38 | 1.50 | 1.20 | 2.99 | 2.99 | 2.41 | Cadherin EGF LAG seven-pass G-type receptor 1 | Celsr1 |
Results are presented in log base 2. A positive deviation of 4 and above and a negative deviation of 4 and below indicates a fold change of 4. Values between 0.585 and −0.585 are considered to be not significant.
T1, T2, and T3 indicate T leukemias; B1, B2, and B3, B leukemias; CT, T control; and CB, B control.
Ratio T-CT and B-CB: mean of the deviation of T1, T2, and T3/T control value and mean of the deviation of B1, B2, and B3/B control value.